HMOX1 and early-onset autosomal dominant Alzheimer disease: Dysregulation of HO activity has been observed in various neurodegenerative conditions, such as Alzheimer’s disease and Parkinson’s disease, where altered HO-1 expression correlates with increased oxidative damage and neuroinflammation [65,66].